Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

5.50
Delayed Data
As of 4:00pm ET
 +0.05 / +0.92%
Today’s Change
3.22
Today|||52-Week Range
6.33
+10.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues13.3M15.0M16.1M19.7M
 
 
 
 
 
Cost of Goods Sold226.0K336.0K376.0K402.0K
 
 
 
 
 
Depreciation And Amortization30.0K28.0K27.0K24.0K
 
 
 
 
 
 
Operating ExpensesGross Income13.0M14.6M15.7M19.3M
 
 
 
 
 
General Expenses12.9M13.0M15.1M17.8M
 
 
 
 
 
Research And Development3.6M4.1M4.6M5.7M
 
 
 
 
 
Total Operating Expenses13.2M13.3M15.5M18.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income102.0K1.7M592.0K1.5M
 
 
 
 
 
Interest Expense On Debt698.0K600.0K584.0K523.0K
 
 
 
 
 
Other Expenses-5.0K-92.0K-27.0K-8.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-601.0K959.0K-19.0K977.0K
 
 
 
 
 
Net Income-601.0K959.0K-19.0K977.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS108.5M109.2M109.7M110.0M
 
 
 
 
 
Shares To Calculate EPS Diluted108.5M113.8M109.7M115.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01$0.01$0.00$0.01
 
 
 
 
EPS Diluted-$0.01$0.01-$0.00$0.01